Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

25 trials with published results (17%)

Research Maturity

103 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.1%

9 terminated out of 147 trials

Success Rate

92.0%

+5.5% vs benchmark

Late-Stage Pipeline

20%

30 trials in Phase 3/4

Results Transparency

24%

25 of 103 completed with results

Key Signals

25 with results92% success

Data Visualizations

Phase Distribution

131Total
Not Applicable (72)
Early P 1 (1)
P 1 (2)
P 2 (26)
P 3 (8)
P 4 (22)

Trial Status

Completed103
Unknown22
Terminated9
Recruiting5
Withdrawn4
Active Not Recruiting3

Trial Success Rate

92.0%

Benchmark: 86.5%

Based on 103 completed trials

Clinical Trials (147)

Showing 20 of 20 trials
NCT04018105Not ApplicableCompletedPrimary

Influence of Preprandial Metformin Administration on Carbohydrate Absorption

NCT05067621Phase 2Active Not Recruiting

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

NCT01864460Not ApplicableCompleted

Improving Autonomic Function and Balance in Diabetic Neuropathy

NCT04341571Phase 2Active Not Recruiting

Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.

NCT05056376Not ApplicableCompleted

Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs

NCT05387551Not ApplicableRecruitingPrimary

CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance

NCT06537401Not ApplicableTerminated

Metabolic Adaptations to High-fat Diet

NCT03938389Phase 4Active Not Recruiting

The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans

NCT06507722Not ApplicableRecruiting

Night Owl Metabolism

NCT06964620Early Phase 1Recruiting

Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes

NCT06901076Not ApplicableCompleted

Effect of a Food Supplement Based on Nigella Sativa Seeds Oil and Vitamin E on Glyco-lipid Parameters in Dysglycemic and Dyslipidemic Perimenopausal Women

NCT05628584Not ApplicableCompleted

High FODMAP Diet With Metformin in preDM

NCT02808182Not ApplicableCompletedPrimary

Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)

NCT04727580Phase 2CompletedPrimary

HSK7653 in Chinese Patients with Impaired Glucose Tolerance

NCT05873322Recruiting

Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma

NCT06495437Not ApplicableNot Yet RecruitingPrimary

Preliminary Safety and Efficacy Study of Extracellular Vesicle Infusion in the Intervention of Age-related Phenotypes With Impaired Glucose Tolerance.

NCT05912348Not ApplicableRecruiting

The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults

NCT05354245Not ApplicableCompleted

Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)

NCT00218998Not ApplicableCompletedPrimary

Effective Endurance Training in Metabolic Syndrome

NCT05914857Phase 2Unknown

Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients

Scroll to load more

Research Network

Activity Timeline